Experience the talks we have captured during various Workshops and Events.
Strategies to Reduce Sedation in Pediatric MRI Exams
2024-07-09
Camilo Jaimes, M.D. (Massachusetts General Hospital, Boston, MA, USA) ESPR 2024, Sevilla, Spain
3D Whole Heart Imaging in Cardiovascular MRI. Exploring the Range of Clinical Applications
2024-03-12
Evangelia Nyktari, M.D. (Cardiovascular MRI Unit, Onassis Cardiac Surgery Center, Athens, Greece)
Next Generation 3D Whole Heart CMR with 100% Respiratory Efficiency: The Power of Collaboration
2024-03-12
René M. Botnar, Ph.D. (School of Biomedical Engineering and Imaging Sciences, King’s College London / Institute of Biological and Medical Engineering, Pontificia Universidad Católica de Chile)
Exploring the Potential of 0.55T MRI: Triumphs, Trials, and Future Horizons
Maxim Guye, MD, PhD (Centre for MR in Biology and Medicine, Aix-Marseille University & University Hospital, Marseille, France)
How high-performance gradients provide new insights into neurological disease
2023-09-08
Susie Y. Huang, MD, PhD (Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA)
Accelerated, High-Resolution TSE Deep Learning Reconstructions for Pediatric MSK MRI
2023-07-21
Sarah Bixby, M.D., MBA (Boston Children’s Hospital; Harvard Medical School, Boston, MA, USA)
SPR Lunch Symposium 2023
Energy Consumption in Medical Imaging: An Uncomfortable Truth
2023-03-28
Elmar Merkle, M.D. (University Hospital Basel, Switzerland)
ECR 2023
How are Energy Prices Affecting Radiology – and what can we do about it?
2023-03-28
Mike Notohamiprodjo, M.D. (DIE RADIOLOGIE, Munich, Germany)
ECR 2023
Pushing the Boundaries of 7 Tesla and Beyond
2022-05-30
Kâmil Uğurbil, PhD (CMRR, Center for Magnetic Resonance Research, Minneapolis, MN, USA)
ISMRM 2022
Cardiac Triggering without ECG: From Research to Clinical Routine?
2022-05-25
Orlando P. Simonetti, Ph.D., MSCMR, FISMRM (The Ohio State University, Columbus, OH, USA)
ISMRM 2022
High Bandwidth Inversion Recovery: Extending the Benefits of CMR to Patients with Cardiac Devices
2022-02-08
Hajnalka Vágó, M.D., Ph.D. (Heart and Vascular Center, Semmelweis University, Budapest, Hungary)
SCMR 2022
The Siemens Healthineers Prostate Cancer AI Detection Software in Clinical Practise
2021-10-21
Anwar R. Padhani MB, BS, FRCP, FRCR (Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London, UK)
PET-MRI for Radiotherapy Planning in Head and Neck Cancer Patients
2021-10-12
Anders Beck Olin, PhD (Rigshospitalet, Copenhagen, Denmark)
The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.
The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist there can be no guarantee that other customers will achieve the same results.
Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens organization for further details.
MAGNETOM 7T and 9.4T are ongoing research. All data shown are acquired using non-commercial systems under institutional review board permission. Siemens does not intend to commercialize the systems. MAGNETOM Terra is currently under development and is not for sale in the US and in other countries. Its future availability cannot be ensured.
The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens.
MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.